Is COVID-19 receiving ADE from other coronaviruses?

Area of Science:

• Immunology
• Virology
• Epidemiology

Background:

• The COVID-19 pandemic presents a puzzling geographic disparity in case severity.
• The Hubei province, China, experienced a disproportionately high number of severe COVID-19 cases compared to other regions.

Purpose of the Study:

• To investigate the potential role of antibody-dependent enhancement (ADE) in the varied severity of COVID-19 cases.
• To explore if prior exposure to other coronaviruses could contribute to severe SARS-CoV-2 infections through ADE.

Main Methods:

• The study hypothesizes a mechanism involving ADE.
• Analysis of immune response modulation, inflammation, lymphopenia, and cytokine storm in severe cases.
• Consideration of the requirement for prior exposure to similar antigenic epitopes.

Main Results:

• Antibody-dependent enhancement (ADE) is proposed as a potential explanation for the observed differences in COVID-19 severity.
• ADE can alter immune responses, potentially causing sustained inflammation, lymphopenia, and cytokine storm.
• These effects align with documented symptoms in severe COVID-19 cases and fatalities.

Conclusions:

• Prior exposure to endemic coronaviruses may prime the immune system for ADE upon SARS-CoV-2 infection.
• ADE offers a plausible explanation for the geographic clustering of severe COVID-19 outcomes observed in Hubei.
• This immunological phenomenon warrants further investigation to understand COVID-19's varied clinical presentations.